Hormone therapy for breast cancer is not the same as hormone replacement therapy at menopause, in which hormones are given to reduce the symptoms that can be associated with menopause.
Unopposed estrogen hormone therapy (E-HT) reduces breast cancer risk, while estrogen plus progestin hormone therapy (EP-HT) increases it, especially with long-term use. The study analyzed data from ...
We conducted a retrospective cohort study of 25,874 female patients with breast cancer age 65 years and older diagnosed between 2007 and 2017 using the SEER-Medicare Health Outcomes Survey (MHOS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results